<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Walker-Warburg syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e>) is a <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> associated with <z:hpo ids='HP_0002269'>neuronal migration disorder</z:hpo> and structural eye abnormalities </plain></SENT>
<SENT sid="1" pm="."><plain>The mutations in the O-mannosyltransferase 1 gene (POMT1) were identified recently in 20% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The authors report on a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WWS</z:e> and a novel POMT1 mutation </plain></SENT>
<SENT sid="3" pm="."><plain>Their patient expressed alpha-dystroglycan (alpha-DG) core protein, but fully glycosylated alpha-DG antibody <z:chebi fb="0" ids="53000">epitopes</z:chebi> were absent, associated with the loss of laminin-binding activity </plain></SENT>
</text></document>